Invesco
ZYME icon

Invesco’s Zymeworks ZYME Stock Holding History

Invesco’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Sell
112,212
-13,418
-11% -$341K ﹤0.01% 2424
2026
Q1 		$3.15M Sell
125,630
-131,950
-51% -$3.12M ﹤0.01% 2361
2025
Q4 		$6.78M Buy
257,580
+163,923
+175% +$3.58M ﹤0.01% 2076
2025
Q3 		$1.6M Buy
93,657
+4,286
+5% +$61.3K ﹤0.01% 2716
2025
Q2 		$1.12M Buy
89,371
+11,165
+14% +$133K ﹤0.01% 2800
2025
Q1 		$931K Buy
78,206
+8,824
+13% +$120K ﹤0.01% 2865
2024
Q4 		$1.02M Sell
69,382
-93,657
-57% -$1.31M ﹤0.01% 2911
2024
Q3 		$2.05M Buy
163,039
+95,301
+141% +$1.04M ﹤0.01% 2588
2024
Q2 		$576K Sell
67,738
-163,443
-71% -$1.45M ﹤0.01% 3216
2024
Q1 		$2.43M Buy
231,181
+174,088
+305% +$1.93M ﹤0.01% 2565
2023
Q4 		$593K Sell
57,093
-57,586
-50% -$459K ﹤0.01% 3129
2023
Q3 		$727K Buy
114,679
+78,392
+216% +$579K ﹤0.01% 3016
2023
Q2 		$314K Buy
+36,287
New +$325K ﹤0.01% 3478
2023
Q1 		– Sell
-51,180
Closed -$402K – 4016
2022
Q4 		$402K Sell
51,180
-258
-0.5% -$1.81K ﹤0.01% 3385
2022
Q3 		$316K Sell
51,438
-2,856
-5% -$17.2K ﹤0.01% 3493
2022
Q2 		$288K Buy
54,294
+7,754
+17% +$46.9K ﹤0.01% 3592
2022
Q1 		$305K Buy
+46,540
New +$415K ﹤0.01% 3632
2021
Q4 		– Sell
-9,871
Closed -$287K – 4112
2021
Q3 		$287K Buy
9,871
+225
+2% +$7.48K ﹤0.01% 3666
2021
Q2 		$335K Buy
9,646
+2,937
+44% +$93.2K ﹤0.01% 3583
2021
Q1 		$212K Buy
+6,709
New +$273K ﹤0.01% 3668

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Invesco's ZYME Position: Q2 2026 in Review

Invesco reduced its Zymeworks (ZYME) stake by 11% in Q2 2026, selling an estimated $341K and leaving 112,212 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

Invesco first reported a position in ZYME in Q1 2021 and has held it in 20 quarters since. The position peaked at $6.78M in Q4 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Invesco held 112,212 shares of Zymeworks worth $2.93M as of Q2 2026.
  • Invesco sold 13,418 Zymeworks shares in Q2 2026, an estimated $341K.
  • Zymeworks made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2424 holding.
  • Invesco first reported a position in Zymeworks in Q1 2021 and has held it in 20 quarters since.
  • Invesco's Zymeworks position peaked at $6.78M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.